Marcus Ramos
Appearances
- DateMay 8, 2023Toupet fundoplication (TF) has been shown to have fewer adverse effects compared to Nissen fundoplication (NF), however, it is unknown whether the advantages of TF persist when comparing outcomes by the distensibility of post-fundoplication lower esophageal sphincter (LES)…
Speakers
Presenter
Sao Paulo University - DateMay 8, 2023Toupet fundoplication (TF) has been shown to have fewer adverse effects compared to Nissen fundoplication (NF), however, it is unknown whether the advantages of TF persist when comparing outcomes by the distensibility of post-fundoplication lower esophageal sphincter (LES)…
Presenter
Speakers
Sao Paulo UniversityUniversity of São Paulo - DateMay 7, 2023BACKGROUND: Despite the advances in the multidisciplinary treatment of gastric adenocarcinoma, the overall 5-year survival remains only 33.3% in North America. R0 resection with adequate lymphadenectomy remains the mainstay therapy…
Presenter
Speakers
Sao Paulo UniversityUniversity of São Paulo - DateMay 19, 2024BACKGROUND: The standard approach for the treatment of patients with locally advanced adenocarcinomas of the gastroesophageal junction (AGEJ) includes perioperative chemotherapy (CMT) or chemoradiation therapy (CRT)…
Presenter
Speakers
- DateMay 19, 2024BACKGROUND: Siewert's topographic classification (SW) has been used for treatment plan of esophagogastric junction adenocarcinomas (EGJA). But recently, molecular classifications categorized EGJA with similar characteristics and prognosis…
Speakers
University of São PauloSao Paulo UniversityPresenter